D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.67%13.45B | 5.04%3.57B | 14.06%3.34B | -23.82%3.26B | 19.04%3.29B | 34.04%13.36B | 14.57%3.39B | 37.53%2.93B | 82.29%4.28B | 9.16%2.76B |
Cost of revenue | -5.92%3.54B | -1.11%932.16M | 5.01%855.82M | -28.60%876.04M | 12.48%880.32M | 24.37%3.77B | 15.54%942.59M | 35.09%815.02M | 86.05%1.23B | -17.65%782.64M |
Gross profit | 3.26%9.91B | 7.40%2.63B | 17.55%2.48B | -21.90%2.38B | 21.64%2.41B | 38.26%9.6B | 14.20%2.45B | 38.50%2.11B | 80.81%3.05B | 25.27%1.98B |
Operating expense | 9.79%9.26B | 10.52%2.5B | 7.11%2.25B | 6.82%2.2B | 14.81%2.31B | 14.17%8.43B | 11.42%2.26B | 16.28%2.1B | 13.35%2.06B | 16.05%2.01B |
Operating profit | -44.20%647.93M | -30.22%131.03M | 1,285.92%239.04M | -81.81%179.81M | 402.61%98.05M | 359.57%1.16B | 63.36%187.78M | 106.23%17.25M | 848.65%988.47M | 78.89%-32.4M |
Net non-operating interest income (expenses) | -82.68%-26.68M | -131.64%-8.61M | -100.46%-6.48M | -65.28%-6.16M | -38.20%-5.43M | 15.26%-14.6M | 9.47%-3.72M | 18.83%-3.23M | 15.82%-3.72M | 16.74%-3.93M |
Non-operating interest income | -15.48%404K | -66.28%58K | 0.00%100K | 56.52%144K | -10.53%102K | 8.64%478K | 52.21%172K | -26.47%100K | -30.30%92K | 93.22%114K |
Non-operating interest expense | 79.57%27.08M | 122.89%8.67M | 97.45%6.58M | 65.07%6.3M | 36.83%5.53M | -14.66%15.08M | -7.82%3.89M | -19.08%3.33M | -16.24%3.82M | -15.38%4.04M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -1.44M | -372K | -433K | 0 | 0 | 0 | ||||
Special income (charges) | 34.98%-44.02M | 12.61%-65.79M | 2,929.60%3.54M | 180.34%17.61M | -56.12%624K | 92.70%-67.7M | 92.04%-75.28M | -100.85%-125K | 467.90%6.28M | -35.57%1.42M |
Less:Other special charges | 116.20%1.63M | 1,046.10%23.4M | -2,929.60%-3.54M | -180.34%-17.61M | 56.12%-624K | 16.67%-10.05M | -141.92%-2.47M | 100.85%125K | -467.90%-6.28M | 35.57%-1.42M |
Less:Write off | -45.48%42.39M | ---- | ---- | ---- | ---- | -91.73%77.75M | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 104.18%2.36M | 104.77%2.16M | 225.36%3.96M | 111.36%1.72M | -177.29%-5.48M | -103.44%-56.54M | -117.01%-45.29M | -100.93%-3.16M | -102.64%-15.18M | -98.46%7.09M |
Income before tax | -43.44%578.16M | -7.98%58.42M | 2,132.83%239.63M | -80.29%192.35M | 415.49%87.76M | 309.79%1.02B | 111.16%63.49M | -85.41%10.73M | 122.21%975.85M | -109.11%-27.82M |
Income tax | -89.14%37.64M | -63.53%11.05M | 631.81%76.53M | -72.81%83.14M | -119,993.69%-133.08M | 180.64%346.6M | 117.40%30.31M | -67.53%10.46M | 90.33%305.72M | -99.89%111K |
Net income | -20.00%540.52M | 42.75%47.37M | 59,641.39%163.09M | -83.70%109.22M | 890.75%220.84M | 436.44%675.65M | 108.41%33.18M | -99.34%273K | 140.59%670.12M | -113.92%-27.93M |
Net income continuous operations | -20.00%540.52M | 42.75%47.37M | 59,423.36%163.09M | -83.70%109.22M | 890.75%220.84M | 436.43%675.65M | 108.41%33.18M | -99.34%274K | 140.59%670.12M | -113.92%-27.93M |
Noncontrolling interests | 4.92%2.3M | 18.42%630K | 1.39%585K | 2.21%555K | -1.85%531K | 1.15%2.19M | 1.14%532K | 10.96%577K | -1.81%543K | -4.92%541K |
Net income attributable to the company | -20.08%538.22M | 43.15%46.74M | 53,733.00%162.51M | -83.77%108.66M | 873.83%220.31M | 444.06%673.46M | 108.26%32.65M | -100.74%-303K | 140.87%669.58M | -114.23%-28.47M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -20.08%538.22M | 43.15%46.74M | 53,733.00%162.51M | -83.77%108.66M | 873.83%220.31M | 444.06%673.46M | 108.26%32.65M | -100.74%-303K | 140.87%669.58M | -114.23%-28.47M |
Gross dividend payment | ||||||||||
Basic earnings per share | -20.08%60.77 | 43.09%5.28 | 45,975.00%18.35 | -83.78%12.26 | 875.08%24.88 | 428.42%76.04 | 108.01%3.69 | -100.85%-0.04 | 133.33%75.6 | -113.74%-3.21 |
Diluted earnings per share | -20.08%60.77 | 43.15%5.2776 | 45,972.65%18.3491 | -83.78%12.26 | 875.08%24.88 | 428.42%76.04 | 108.00%3.6867 | -100.86%-0.04 | 139.01%75.6 | -114.09%-3.21 |
Dividend per share | 0.00%7.5 | 0.00%5 | 0 | 0.00%2.5 | 0 | 0.00%7.5 | 0.00%5 | 0 | 0.00%2.5 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |